{{Rsnum
|rsid=786870
|Gene=APBB1IP
|Chromosome=10
|position=26774694
|Orientation=minus
|GMAF=0.1501
|Gene_s=APBB1IP
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=137
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 4.5 | 37.5 | 58.0
| HCB | 0.7 | 19.3 | 80.0
| JPT | 0.0 | 12.4 | 87.6
| YRI | 0.0 | 10.9 | 89.1
| ASW | 1.8 | 17.5 | 80.7
| CHB | 0.7 | 19.3 | 80.0
| CHD | 2.8 | 23.1 | 74.1
| GIH | 3.0 | 37.6 | 59.4
| LWK | 0.0 | 3.6 | 96.4
| MEX | 5.2 | 25.9 | 69.0
| MKK | 0.6 | 12.2 | 87.2
| TSI | 7.8 | 34.3 | 57.8
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22228203
|Trait=None
|Title=A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network.
|RiskAllele=
|Pval=5E-7
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}